FISV vs TECH · P/E 8.4, rev $20.46B vs P/E 65, rev $1.22B
Fiserv, Inc. Common Stock (FISV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Fiserv, Inc. Common Stock (FISV) is a software company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported FISV revenue for 2024-12-31 was $20.46B. Net income was $3.18B. Revenue was up 7.1% from 2023-12-31 to 2024-12-31. FISV currently screens at market cap $26.42B and trailing P/E 8.4.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
FISV currently screens at market cap $26.42B and trailing P/E 8.4. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the FISV and TECH stock pages for the full models.
Not investment advice.